Microbiome identification and bacteriophage formulations
US-2024123002-A1 · Apr 18, 2024 · US
US9730883B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9730883-B2 |
| Application number | US-201214236849-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 3, 2012 |
| Priority date | Aug 5, 2011 |
| Publication date | Aug 15, 2017 |
| Grant date | Aug 15, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided is a novel lactic acid bacterium strain which is capable of suppressing production of volatile sulfur compounds by oral bacteria, has no cariogenicity and no causative role in infective endocarditis, and is safe in an oral cavity, and provided is an agent for preventing, improving and/or treating oral diseases and discomforts by use of the bacterial strain. An agent for preventing and/or treating an oral disease, containing, as an active ingredient, at least one lactic acid bacterium selected from Lactobacillus crispatus, Lactobacillus fermentum, Lactobacillus gasseri , and Streptococcus mitis and having all of the following properties (1) to (6): (1) having no ability to produce a volatile sulfur compound (VSC); (2) having no ability to produce water-insoluble glucan; (3) having adhesiveness to a tooth surface and/or an oral cell; (4) having a growth inhibitory effect on a bad breath-causing bacterium and/or a periodontal pathogen; (5) having no causative role in infective endocarditis; and (6) having no cariogenicity.
Opening claim text (preview).
The invention claimed is: 1. A method for inhibiting growth of at least one pathogenic bacterium, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503), wherein the at least one pathogenic bacterium is at least one selected from the group consisting of Porphyromonas gingivalis, Prevotella intermedia, Aggregatibacter actinomycetemcomitans, Streptococcus mutans, Streptococcus sobrinus, Fusobacterium nucleatum , and Tannerella forsythia. 2. The method of claim 1 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium. 3. The method of claim 1 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 4. The method according to claim 3 , wherein the food or the drink is a fermented product. 5. The method according to claim 1 , wherein the at least one pathogenic bacterium is at least one selected from the group consisting of Porphyromonas gingivalis, Prevotella intermedia, Aggregatibacter actinomycetemcomitans, Streptococcus mutans , and Streptococcus sobrinus. 6. The method according to claim 1 , wherein the at least one pathogenic bacterium is at least one selected from the group consisting of Porphyromonas gingivalis, Fusobacterium nucleatum , and Tannerella forsythia. 7. A method for preventing and/or improving bad breath, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503). 8. The method of claim 7 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 9. The method according to claim 8 , wherein the food or the drink is a fermented product. 10. The method of claim 7 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium. 11. A method for preventing and/or treating gingivitis, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503). 12. The method of claim 11 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 13. The method according to claim 12 , wherein the food or the drink is a fermented product. 14. The method of claim 11 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium. 15. A method for improving bad breath, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503). 16. The method of claim 15 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 17. The method according to claim 16 , wherein the food or the drink is a fermented product. 18. The method of claim 15 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium. 19. A method for treating gingivitis, the method comprising administering to a subject in need thereof an effective amount of at least one lactic acid bacterium selected from the group consisting of Lactobacillus crispatus YIT 12319 (FERM BP-11500), Lactobacillus fermentum YIT 12320 (FERM BP-11501), Lactobacillus gasseri YIT 12321 (FERM BP-11502), and Streptococcus mitis YIT 12322 (FERM BP-11503). 20. The method of claim 19 , wherein administering the at least one lactic acid bacterium comprises administering a food or a drink comprising the lactic acid bacterium. 21. The method according to claim 20 , wherein the food or the drink is a fermented product. 22. The method of claim 19 , wherein administering the at least one lactic acid bacterium comprises administering an oral composition comprising the lactic acid bacterium.
Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates · CPC title
Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title
Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title
Bacteria; Culture media therefor · CPC title
Adding ingredients (adding preservatives A23B70/10) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.